(Q28367498)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Pharmacokinetics of hypoxic cell radiosensitizers: a review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

In vivo combination of misonidazole and the chemotherapeutic agent CCNU

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Potentiation of chemotherapy by hypoxic cell radiation sensitizers--a review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Hypoxic cell radiosensitizers as potential adjuvants to conventional chemotherapy for the treatment of cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

The use of microparticulate reversed-phase packing in high-pressure liquid chromatography of compounds of biological interest

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Comparison of the properties of metabolites of CCNU

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationships

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

In vivo-in vitro clonogenic assays in a human tumour xenograft with a high plating efficiency

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Nitrosourea pharmacodynamics in relation to the central nervous system

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Relationship between Misonidazole Toxicity and Core Temperature in C3H Mice

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011404

Hydroxylation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea

27 November 2018

1 reference

12 December 2020

Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

The pharmacokinetics of misonidazole in the dog

1 reference

12 December 2020

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors—I. Adriamycin

1 reference

12 December 2020

Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice

1 reference

12 December 2020

Structure-pharmacokinetic relationships for misonidazole analogues in mice

1 reference

12 December 2020

Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts

1 reference

12 December 2020

Studies on the O-demethylation of misonidazole by rat liver microsomes

1 reference

12 December 2020

Enhancement of chemotherapy agents

1 reference

12 December 2020

Chemical properties of nitrosoureas: implications for interaction with misonidazole

1 reference

12 December 2020